This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Katia Karalis: Innovator in Psoriasis Treatment
Introduction
Katia Karalis is a prominent inventor based in Tarrytown, NY (US). She has made significant contributions to the field of dermatology, particularly in the treatment of psoriasis. Her innovative approach has garnered attention in the medical community.
Latest Patents
Katia holds a patent for her work titled "Treatment Of Psoriasis With Interferon Induced Helicase C Domain 1 (IFIH1) Inhibitors." This patent represents a breakthrough in the treatment options available for patients suffering from psoriasis, showcasing her dedication to improving patient outcomes.
Career Highlights
Katia is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her role at this leading biopharmaceutical company allows her to collaborate with other experts in the field and contribute to innovative therapies.
Conclusion
Katia Karalis is a trailblazer in the treatment of psoriasis, with her patent and work at Regeneron Pharmaceuticals, Inc. highlighting her commitment to medical innovation. Her contributions are paving the way for new treatment options that can significantly improve the lives of patients.